The Latest Breaking News from Obesity

Lancet study uses data from 204 countries to paint a grim picture of what it called an ‘unprecedented global epidemic’.

Since the 1990s, the proportion of the world’s population who are overweight (with a body mass index of 25–30) or obese (with a body mass index of 30 or above) has doubled.

In many countries, buying food at supermarkets, convenience stores and online has become the norm. But what’s the convenience of modern food shopping doing to our health?

Scientists have pinpointed and described unusual subtypes of fat cells that may help scientists explain why gut fat is linked to poor health. The research could open up new avenues for medical treatments.

Skye Bioscience is trying to establish a presence in the weight-loss drug market.

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity. This includes Wegovy (the weight-loss dose of Ozempic, or semaglutide) and Mounjaro (one of the brand names for tirzepatide).

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, pharmaceutical giants like Eli Lilly and Company (LLY), Novo Nordisk (NVO), and Amgen (AMGN) are betting big on next-generation weight loss treatments to dominate this booming market. Keeping reading.

‘There are a lot of people right now who want access to the medication and can’t get it’

In his latest effort to tackle rising health concerns, Prime Minister Narendra Modi has called for a nationwide movement to combat obesity and promote healthier eating habits Read further on Dynamite News: